Kintara adjourns special meeting to Oct 4 due to insufficient votes on merger-related proposals

TuHURA Biosciences, Inc./NV

Special Meeting on Sept 20, 2024 adjourned to Oct 4, 2024 because insufficient votes on Proposal 3 (increase authorized shares to 400M) and Proposal 5 (reincorporation to Delaware).
Only the adjournment proposal was voted on and approved (24,945,610 for, 6,079,445 against, 587,527 abstain).
The merger with TuHURA Biosciences is conditioned on approval of these proposals.
Stockholders who already voted do not need to revote; proxies remain valid.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.